2.
Quick Guide for Clinicians Based on TIP 45
Detoxification and Substance Abuse Treatment
TIP 45 Detoxification and Substance Abuse
Treatment (free resource)
American Society of Addiction Medicine‟s Patient
Placement Criteria 2-Revised
Diagnostic and Statistical Manual IV TR
3.
To inform participants about the basic
principles of withdrawal from alcohol and
other drugs and to help participants
understand their role in caring for persons in
a community-based detoxification setting
To help participants meet the legal
requirements for detox providers
4. After completion of this class participants will:
1. Understand the laws and regulations that govern social
and modified medical model detoxification programs in
Nevada (NRS)
2. Have improved knowledge of the biopsychosocial aspects
of withdrawal (signs and symptoms, ASAM dimensions)
3. Have knowledge of the most common medications used
in withdrawal management
4. Understand the parameters and limitations of a social
model setting (NRS, medications, care coordination)
5. Understand their role in providing care in a detox setting
(limitations, guidelines, engagement, retention, NHIPPS)
6. Understand and successfully demonstrate how to
measure, record and report vital signs
7. Have met one of the legal requirements established in
NRS for detox providers
5.
Nevada Administrative Code, Chapter 449
for Medical and Other Related FacilitiesThe Bureau of Health Care Quality and
Compliance formerly Bureau of Licensure and Certification
Nevada Revised Statutes, Chapter 458SAPTA
Nevada Revised Statutes, Chapter 641C Alcohol, Drug And Gambling Counselors
And Detoxification Technicians- Board of
Examiners for Alcohol, Drug, and Gaming
Counselors
6.
Education / training (this class) initially and every two
years
Seizure care
Tuberculosis and communicable diseases
Current certification in Cardiopulmonary
Resuscitation
Pass skills test for measuring, recording and
reporting vital signs
7.
The State Board of Health's regulations governing the control
of communicable diseases are found in the Nevada
Administrative Codes (NAC) Chapter 441A
These regulations mandate public health
professionals, medical providers, laboratories and
others in Washoe County to report approximately
50 diseases or conditions to the District Health
Department Communicable Disease Program.
All reported information is CONFIDENTIAL.
8.
Prior to the 1970‟s public intoxication was
commonly treated as a criminal offense.
Drunk tanks, withdrawal with no medical
intervention.
From this- arose the medical model and
social models of detoxification.
9.
According to the U.S. Department of Health
and Human Services, Substance Abuse and
Mental Health Administration (SAMHSA)
detoxification is a set of interventions aimed
at managing acute intoxication and
withdrawal.
Clearing of toxins from the body.
The primary goal is to build a therapeutic
alliance and motivate clients to enter
treatment.
10. Social model substance abuse treatment
programs concentrate on providing
psychosocial services.
Trained detox personnel and other clinicians
provide supportive withdrawal management
services in addition to individual and family
counseling and coordination of care.
11.
A clinically managed residential detoxification
that may be delivered by appropriately trained
staff, who provide 24-hour
supervision, observation and support for patients
who are intoxicated or experiencing withdrawal.
Clinically managed detoxification is characterized
by its emphasis on peer and social support.
Intoxication and withdrawal signs and symptoms
are sufficiently severe enough to require 24-hour
structure and support but not severe enough to
warrant the resources of a Level III.7-D medically
monitored inpatient detoxification.
12.
Medically monitored inpatient detoxification
is an organized service delivered by medical
and nursing professionals, which provides for
24 hour medically supervised evaluation and
withdrawal management in a permanent
facility with inpatient beds. Services are
delivered under a defined set of physicianapproved policies and physician monitored
procedures or clinical protocols.
13. Modified and full medical detox can be characterized
by:
directed by a physician
staffed by other health care personnel
range from hospital-based inpatient programs to
free-standing medically based residential
programs in hospitals or in community facilities
can draw on various medical resources within the
community
designed to treat more serious substance
withdrawal syndromes that require the use of
detox medications and medical oversight
14. 1. Evaluation
2. Stabilization
3. Fostering client readiness for and entry into
treatment
*a detox process that does not incorporate
all three critical components is considered
incomplete and inadequate
15. INTAKE
Client presents for
SM detox service
Ensure Client has
medical clearance for
SM Detox
Ensure client has
had a drug test
Establish diagnosis
and check for
prescription or OTC
detox medication
Search for Client
Profile in NHIPPS, if
none exists, create a
new profile record
NHIPPS -- Treatment Flowchart
SOCIAL MODEL DETOX EPISODE
revised 09/08 - MMD / SAPTA
Clearance can be granted by
ER or other qualified medical
personnel
ADMISSION /
ASSESSMENT
Complete Admission Record for ASAM Level III.2D
Lab license required for testing. Testing is critical to identify
drug used, determine diagnosis, increase client safety and
reduce agency liability
Complete NHIPPS assessment including HDPC within
24 hours of admission
Note in HDPC clinical summary that only ASAM
Intoxication / Withdrawal is the driving dimension
The assessment may be left “in progress” so it can be reviewed when client is admitted
to the next level of care or if the client does not stay to complete the assessment
Any staff with chart entry privileges can do
this if a diagnosis has been established
TREATMENT
Develop detox treatment plan (not the NHIPPS
treatment plan) to
address ASAM withdrawal dimension
Detox TX plan can be recorded in Chart Note
Monitor for withdrawal symptoms, record vitals
and observations in NHIPPS Chart Note or
paper file
Complete one NHIPPS Progress Note per day
Progress Note should include observation,
vitals summary, engagement attempts,
client participation and readiness for care
TX plan should engage client, monitor withdrawal
symptoms and medications, and introduce client to
individual or group therapeutic events .
DISCHARGE /
TRANSFER
Once client has adequately
completed detox, review
assessment and mark it complete
Create
Discharge Record – refer to
appropriate level of care
Goal is 40% engagement in
continued care after detox
Complete discharge HDPC
Complete within 5 days of
actual client discharge
Complete intra or inter agency
transfer steps (Client must consent
to inter-agency transfer of his / her
records)
Open completed discharge record in the
activity list to access discharge HDPC
16.
The American Society of Addiction Medicine Patient
Placement Criteria 2nd Edition Revised (ASAM-PPC2R) is the evidenced-based literature referenced in
support of the Health Division Placement Criteria
required by SAPTA.
17. The placement criteria describe levels of
treatment that are differentiated by the
following characteristics:
(1) degree of direct medical management
provided,
(2) degree of structure, safety, and security
provided, and
(3) degree of treatment intensity provided.
18. Dimension 1
Dimension 2
Dimension 3
Acute Intoxication
&/or Withdrawal
Potential
Biomedical
Conditions &
Complications
Emotional,
Behavioral, or
Cognitive
Conditions &
Complications
Dimension 4
Dimension 5
Dimension 6
Readiness to
Change
Relapse,
Recovery / Living
Continued Use or
Environment
Continued
Problem Potential
19. The Goals of Care:
1. Avoidance of potentially hazardous
consequences of discontinuation
2. Facilitation of the client‟s completion of
detoxification
3. Promotion of client dignity
20. Are there current physical illnesses?
Are there chronic conditions that affect
treatment?
21.
Persons undergoing withdrawal are in
profound medical and personal crisis!
Withdrawal can cause and/or exacerbate
physical, emotional, psychological or mental
problems.
22.
NAC 449.1214 Medical Clearance requires a physical
assessment/exam by an MD, PA, NP, or RN within 24 hours to
ensure that a social model is appropriate
◦ Diagnosis
◦ Detox medications
◦ Special instructions
Clients are provided with continuous monitoring based upon
established written and MD approved policies and procedures
(see sample)
*Drug test
Comply with NAC 449.144 Medications
*Not yet required but preferred
23.
General health history
Mental status
General and physical
assessment and neuro
check
Vital signs
Patterns of use
Urine toxicology
Past treatment or
withdrawal
Biomedical
Demographics
Living conditions
Violence/suicide risk
Transportation
Financial situation
Dependent children
Legal status
Physical, sensory or
cognitive disabilities
Psychosocial
24.
Medication assist
Right container
Labeled
◦
◦
◦
◦
◦
◦
Client name
Medication
Dosage
Instructions
Prescribing physician
Not expired!
NAC 449.144
Detox staff make
medication available
◦
◦
◦
◦
Observe
Document
Monitor
Contact prescribing or ER
physician as needed
“Medication Assist”
25.
Change in mental status
Increasing anxiety
Hallucinations
Temperature greater than 100.4 (infectious)
Significant increase/decrease in vitals
Insomnia-prolonged
Upper and lower GI bleeding
Change in responsiveness- pupils
Heightened deep tendon reflexes
*Immediate MH needs: Suicidality, Anger and Aggression
30.
One of the neurotransmitters playing a major
role in addiction is dopamine.
As a chemical messenger, dopamine is similar
to adrenaline.
Dopamine affects brain processes that
control movement, emotional response, and
ability to experience pleasure and pain.
Regulation of dopamine plays a crucial role in
our mental and physical health.
31.
32.
33.
34.
35.
36.
37.
38.
39.
40.
41.
42.
43.
44.
45.
46.
47.
48.
49.
50.
51.
52.
53.
54. Your Brain on
Drugs
1-2 Min
3-4
5-6
6-7
7-8
8-9
9-10
10-20
20-30
Photo courtesy of Nora Volkow, Ph.D. Mapping cocaine
binding sites in human and baboon brain in vivo. Fowler
JS, Volkow ND, Wolf AP, Dewey SL, Schlyer DJ, Macgregor
RIR, Hitzemann R, Logan J, Bendreim B, Gatley ST. et al.
Synapse 1989;4(4):371-377.
55. Your Brain
After Drugs
Normal
Cocaine Abuser
(10 days)
Cocaine Abuser
(100 days)
Photo courtesy of Nora Volkow, Ph.D. Volkow ND, Hitzemann R, Wang C-I, Fowler IS, Wolf AP, Dewey SL. Long-term frontal brain metabolic changes
in cocaine abusers. Synapse 11:184-190, 1992; Volkow ND, Fowler JS, Wang G-J, Hitzemann R, Logan J, Schlyer D, Dewey 5, Wolf AP. Decreased
dopamine D2 receptor availability is associated with reduced frontal metabolism in cocaine abusers. Synapse 14:169-177, 1993.
57. The Memory of
Drugs
Front of Brain
Amygdala
not lit up
Amygdala
activated
Back of Brain
Nature Video
Photo courtesy of Anna Rose Childress, Ph.D.
Cocaine Video
58. Partial Recovery of Brain Dopamine
Transporters in Methamphetamine (METH)
Abuser After Protracted Abstinence
3
0
ml/gm
Normal Control
METH Abuser
(1 month detox)
METH Abuser
(24 months detox)
Source: Volkow, ND et al., Journal of Neuroscience 21, 9414-9418, 2001.
59.
60.
Pharmacologic therapies are indicated for use
in persons with substance use disorders to
prevent life-threatening withdrawal
complications such as seizures and delirium
tremens, and to increase compliance with
psychosocial forms of addiction treatment.
61.
Methamphetamine is a powerful central nervous
system stimulant that strongly activates multiple
systems in the brain. Methamphetamine is closely
related chemically to amphetamine, but the central
nervous system effects of methamphetamine are
greater.
Methamphetamine causes a tremendous release of
dopamine into the synapse and causes
displacement in little sacs of the dopamine
transmitters.
62. Forms of Methamphetamine
Methamphetamine Powder
Description: Beige/yellowy/off-white powder
Base / Paste Methamphetamine
Description: ‘Oily’, ‘gunky’, ‘gluggy’ gel, moist, waxy
Crystalline Methamphetamine
Description: White/clear crystals/rocks;
‘crushed glass’ / ‘rock salt’
63.
The effects of methamphetamine include increased activity,
decreased appetite, and a sense of well-being that can last
from six to eight hours.
The drug has limited medical uses for the treatment of
narcolepsy, attention deficit disorders, and obesity.
Increase wakefulness and physical activity and decrease
appetite.
Methamphetamine can also cause a variety of cardiovascular
problems, including rapid heart rate, irregular heartbeat, and
increased blood pressure. Hyperthermia (elevated body
temperature) and convulsions may occur with
methamphetamine overdose, and if not treated immediately,
can result in death.
(National Institute on Drug Abuse, Methamphetamine: Abuse and Addiction, April 1998.)
64.
Anxiety
Confusion
Insomnia
Mood disturbances
Violent behavior
Psychotic features, including paranoia, visual and auditory
hallucinations, and delusions (for example, the sensation of
insects creeping under the skin). Psychotic symptoms can
sometimes last for months or years after methamphetamine
abuse has ceased, and stress has been shown to precipitate
spontaneous recurrence of methamphetamine psychosis in
formerly psychotic methamphetamine abusers.
65.
Peak period: 1-3 days after cessation
Duration: 5–7 days depending on various
factors
Signs: Social withdrawal, psychomotor
retardation, hypersomnia, hyperphagia
Symptoms: Depression, anhedonia, suicidal
thoughts and behavior, paranoid delusions
66.
Peak period: 24 hours after cessation
Duration: 5–7 days depending on various
factors
Signs:
Anxiety, Restlessness, Irritability, Sleeplessne
ss
Symptoms: Depression
67.
Management of alcohol withdrawal is based
on the client‟s history and current clinical
status. The single best predictor of the
likelihood of future withdrawal symptoms
when alcohol is concerned is the patient's
previous history, e.g., the presence or
absence of seizures or delirium tremens
68.
Peak period: 1-3 days after cessation
Duration: depends on various factors
Signs: Elevated blood pressure, pulse and
temperature, hyperarousal, agitation, restlessnes
s, cutaneous
flushing, tremors, diaphoresis, dilated
pupils, ataxia, clouding of
consciousness, disorientation
Symptoms: Anxiety, panic, paranoid
delusions, illusions, visual and auditory
hallucinations (often derogatory and
intimidating)
69.
Valium- (Diazepam) is a
benzodiazepine with a medium to
long duration of action. Used for
withdrawal to decrease blood
pressure, to relieve anxiety, to
help relax muscles or relieve
muscle spasm.
Ativan- (Temesta or Lorazepam) is
a benzodiazepine with short to
medium duration of action.
Atenolol – (Tenormin) is a betablocking agent used in the
treatment of high blood pressure,
used to relieve angina, and in
heart attack patients to help
prevent additional heart attacks. It
is also used to correct irregular
heartbeat, prevent migraine
headaches, and to treat tremors.
Clonidine (Catapres)- lowers blood
pressure by decreasing the levels
of certain chemicals in your blood.
Reduces anxiety.
70.
At the first sign- summon trained medical
personnel
Prevent injury-protect head, move nearby
objects
Place on side if client is vomiting
Soothing, calm voices/actions
Medical Evaluation!
71.
Is a potentially fatal form of alcohol withdrawal.
Symptoms may begin a few hours after the
cessation of ethanol but may not peak until 4872 hours. Emergency Room Physicians must
recognize that the presenting symptoms may not
be severe and identify those at risk for
developing DT. For patients in DT, early
recognition and therapy are necessary to prevent
significant morbidity and death.
73.
Peak period: 1-3 days after cessation
Duration: 7-14 days depending on various
factors
Signs: Drug
seeking, mydriasis, piloerection, diaphoresis,
rhinorrhea, lacrimation, diarrhea, insomnia, el
evated blood pressure and pulse (mild)
Symptoms: Intense desire for drugs, muscle
cramps, arthralgia, anxiety, nausea, vomiting,
malaise
74.
Represent a diverse class and include
sedative-hypnotics, stimulant and
hallucinogens
Clubs/raves
Adolescent/young adult
75.
Common household products that give off mind-altering
chemical fumes when sniffed
Paint thinner, fingernail polish
remover, glues, gasoline, cigarette lighter fluid, and nitrous
oxide, whipped cream, hair and paint sprays, and computer
cleaners
The chemical structure of the various types of inhalants is
diverse, making it difficult to generalize about the effects of
inhalants.
Inhalant users are also at risk for Sudden Sniffing Death
(SSD), which can occur when the inhaled fumes take the place
of oxygen in the lungs and central nervous system.
76.
Withdrawal from benzodiazepines such as
Xanax, Librium, Ativan, etc. cannot be
managed in a social model detox setting
Withdrawal must be overseen by a physician
Detox can be done on an outpatient basis
77. INTAKE
Client presents for
SM detox service
Ensure Client has
medical clearance for
SM Detox
Ensure client has
had a drug test
Establish diagnosis
and check for
prescription or OTC
detox medication
Search for Client
Profile in NHIPPS, if
none exists, create a
new profile record
NHIPPS -- Treatment Flowchart
SOCIAL MODEL DETOX EPISODE
revised 09/08 - MMD / SAPTA
Clearance can be granted by
ER or other qualified medical
personnel
ADMISSION /
ASSESSMENT
Complete Admission Record for ASAM Level III.2D
Lab license required for testing. Testing is critical to identify
drug used, determine diagnosis, increase client safety and
reduce agency liability
Complete NHIPPS assessment including HDPC within
24 hours of admission
Note in HDPC clinical summary that only ASAM
Intoxication / Withdrawal is the driving dimension
The assessment may be left “in progress” so it can be reviewed when client is admitted
to the next level of care or if the client does not stay to complete the assessment
Any staff with chart entry privileges can do
this if a diagnosis has been established
TREATMENT
Develop detox treatment plan (not the NHIPPS
treatment plan) to
address ASAM withdrawal dimension
Detox TX plan can be recorded in Chart Note
Monitor for withdrawal symptoms, record vitals
and observations in NHIPPS Chart Note or
paper file
Complete one NHIPPS Progress Note per day
Progress Note should include observation,
vitals summary, engagement attempts,
client participation and readiness for care
TX plan should engage client, monitor withdrawal
symptoms and medications, and introduce client to
individual or group therapeutic events .
DISCHARGE /
TRANSFER
Once client has adequately
completed detox, review
assessment and mark it complete
Create
Discharge Record – refer to
appropriate level of care
Goal is 40% engagement in
continued care after detox
Complete discharge HDPC
Complete within 5 days of
actual client discharge
Complete intra or inter agency
transfer steps (Client must consent
to inter-agency transfer of his / her
records)
Open completed discharge record in the
activity list to access discharge HDPC
78. Client Profile
•Profile record should be the first or
bottom record in the client activity list
– this is controlled by profile date
•Always assume there is a profile for
the client before creating one – in
other words, search for a profile
before entering a new one
•If your agency has multiple
treatment locations where intake
could occur, techs and counselors
should have access to view client
records from the Business Level and
should also have the ability to move
to any treatment location within the
system to share records with the
detox treatment location
•TURN YOUR POPUP BLOCKER OFF
BEFORE ENTERING A NEW CLIENT
PROFILE – this way, if one already
exists at your agency, the system will
find it and notify you
•Enter only the city in Birth City field
79. Admission Record (page 1)
•Do not select Transitional Housing as the admission type for a detox admission
– detox is a residential admission, transitional housing is paired with outpatient
services
•Do not enter dollar signs or decimal places in monetary fields
80. Admission record (page 2)
Admission justification should be written by a counselor, however if a technician must enter an admission record, the
justification should rely on a medical record that indicates a diagnosis of intoxication or withdrawal and can include drug
and other test results and prior admissions for detox within 30 days of the current admission. The technician should
contact supervisor as soon as possible to schedule a complete assessment.
Example 1: Client arrived at 11:00pm, cleared through ER. ER documentation states intoxication (alcohol) diagnosis,
cleared for social detox.
Example 2: Client assessed by Dr. Jones, medically cleared with intoxication diagnosis for social detox treatment.
81. Detox TX Plan (Chart Note)
•Chart note is accessed from the toolbar in the Client Activity List screen
•Exercise care when entering information in the Chart Note as it cannot be deleted
•If creating a treatment plan for detox, enter Detox TX Plan for as the topic
82. Screening
•The screening record contains questions about gambling behavior and should be
completed
•The screening score is not the justification for an assessment, it is a tool to be used by
a provider to establish a business process
83. Assessment / General - Leave In Progress
•Leave the assessment in progress for clinical staff at the next level of care to review
and modify if necessary
85. Assessment / HDPC (ASAM)
•If the HDPC record is idle for more than 5 minutes, it is advisable to copy the clinical summary before saving
the record. This will ensure that if the current NHIPPS session is terminated, the text entered into the
clinical summary field will be stored on the computer Clipboard and can be copied back into this record
88. Reflects Prochaska & DiClemente‟s
“Stages of Change Model”
An individual‟s emotional and cognitive
awareness of the need to change and his
or her level of commitment to and
readiness for change indicate his or her
degree of cooperation with treatment…
89. Precontemplation- The substance use has
not considered change and does not plan to
make changes in the near future. The may
be partly or completely unaware that the
problem even exists.
Strategies- Rapport & trust building, raise
doubts or concerns, elicit CSO‟s assistance.
TIPS 35, 1999
89
90. Contemplation client is aware of the
problem and starts to examine the
possibility of change. These are individuals
who are ambivalent (seeing reasons to
change and at the same time seeing
reasons not to change). They are sitting on
a teeter-totter. The “Ya, but..”
Strategies- Normalize the ambivalence, elicit
self-motivation statement from the client, “tip” the
scale.
TIPS 35, 1999
90
91. Preparation- The individual can see the
advantages to change and is aware that
they outweigh the disadvantages. They
have a strengthened commitment to change
and may have even set a date to quit use or
have decreased their use. It‟s a window that
opens for a short period.
Strategies- Clarify goals, offer a menu of
options, negotiate strategies for change, help client
to enlist social support, make a public
announcement.
TIPS 35, 1999
91
92. Action - The individual chooses strategies
to change and actively works towards
change. They are taking steps to change.
Often they are behaviorally definable
differences. However, they have not reached
a stable state.
Strategies- Continue to engage and reinforce any
changes with a focus on the importance of
remaining in recovery, support small step, identify
high-risk situations, help client assess current
social support system.
TIPS 35, 1999
92
93. Maintenance- The individual works to
sustain any gains made during the action
phase. They have achieved the initial goals
towards change and now are working
towards maintaining them.
Strategies- “fire-escape” plan, review long-term
goals, sample drug-free sources of pleasure, roleplay & practice coping skills.
TIPS 35, 1999
93
94. Recurrence- the client experiences a
recurrence of the symptoms and now has to
face the consequences.
Assist in reentry and commend any willingness to
consider continued change.
Explore the recurrence as a learning experience
and learning opportunity.
Elicit social support
Explore alternative coping strategies.
TIPS 35, 1999
94
95. Relapse
Relapse is an act or instance of
backsliding, worsening, or subsiding, and
may be the common denominator in one
of the outcomes of treatments designed to
address psychological problems and
health-related behaviors especially those
related to alcohol and drug misuse.
96.
97.
Vital signs include the measurement of:
temperature, respiratory rate, pulse, blood pressure
and, where appropriate, blood oxygen saturation.
Vital Signs can:
1.
2.
3.
Identify the existence of an acute medical problem.
Are a means of rapidly quantifying the magnitude of an
illness and how well the body is coping with the resultant
physiologic stress. The more abnormal the vitals, the sicker
the clients.
Vital signs are a marker of chronic disease states (e.g.
hypertension is defined as chronically elevated blood
pressure).
98.
The room should be quiet, warm and well
lit.
Prior to measuring vital signs, the clients
should have had the opportunity to sit for
approximately five minutes so that the
values are not affected by the exertion.
All measurements are made while the client
is seated.
100.
Respirations are recorded as breaths per
minute
They should be counted for at least 30
seconds
Try to measure discretely so that the client
does not consciously alter their rate of
breathing
Counting breaths can be done by observing
the rise and fall of the client‟s chest while
you appear to be taking their pulse.
Normal range is between 12 and 20.
101.
Generally done by palpating the radial
impulse
Measure the rate of the pulse (recorded in
beats per minute).
Count for 30 seconds and multiply by 2 (or
15 seconds x 4). If the rate is particularly
slow or fast, it is probably best to measure
for a full 60 seconds
Normal range is between 60 and 100.
102.
Blood pressure is the force of blood pushing
against the walls of arteries – the blood vessels
that carry blood away from the heart to other parts
of the body
Blood pressure can rise and fall depending on a
person‟s general health, their level of physical
activity, the time of day and many other factors
Normal range is Systolic: 100 to 140.
Diastolic: Equal to or less than 90
103.
Dependent on agency policies
Social Model Detox reports all abnormal
vital sign measurements to licensed
healthcare professionals
Medical Detox has option to medicate and
treat the individual based on physicianapproved protocols and physician„s orders
Notas do Editor
ETOH Withdrawal 291.81Amphetamine Withdrawal 292.0Cannabis – no withdrawal- Cocaine Withdrawal 292.0Opiate Withdrawal – 292.0Inhalant Withdrawal –Polysubstance Withdrawal-Benzodiazepine Withdrawal The Diagnostic and Statistical Manual of Mental Disorders (DSM) is published by the American Psychiatric Association and provides a common language and standard criteria for the classification of mental disorders. It is used in the United States and in varying degrees around the world, by clinicians, researchers, psychiatric drug regulation agencies, health insurance companies, pharmaceutical companies and policy makers.The DSM has attracted controversy and criticism as well as praise. There have been five revisions since it was first published in 1952, gradually including more mental disorders, though some have been removed and are no longer considered to be mental disorders.The manual evolved from systems for collecting census and psychiatric hospital statistics, and from a manual developed by the US Army, and was dramatically revised in 1980. The last major revision was the fourth edition ("DSM-IV"), published in 1994, although a "text revision" was produced in 2000. The fifth edition ("DSM-V") is currently in consultation, planning and preparation, due for publication in May 2013.[1]
CERTIFICATION OF DETOXIFICATION TECHNICIANS NRS 641C.500 Adoption of regulations governing certification; scope of regulations; prohibitions; inapplicability of certain provisions of chapter. 1. The Board may, by regulation, provide for the certification of a person as a detoxification technician. 2. Any regulation adopted pursuant to subsection 1 must be consistent with the provisions of chapter 622A of NRS and must include, without limitation, provisions relating to: (a) The requirements for submitting an application for a certificate, including, without limitation, the submission of a complete set of fingerprints pursuant to NRS 641C.260; (b) The scope of practice for a person who is issued a certificate; (c) The conduct of any investigation or hearing relating to an application for a certificate; (d) The examination of an applicant for a certificate or a waiver of examination for an applicant; (e) The requirements for issuing a certificate or provisional certificate; (f) The duration, expiration, renewal, restoration, suspension, revocation and reinstatement of a certificate; (g) The grounds for refusing the issuance, renewal, restoration or reinstatement of a certificate; (h) The conduct of any disciplinary or other administrative proceeding relating to a person who is issued a certificate; (i) The filing of a complaint against a person who is issued a certificate; (j) The issuance of a subpoena for the attendance of witnesses and the production of books, papers and records; (k) The payment of fees for: (1) Witnesses, mileage and attendance at a hearing or deposition; and (2) The issuance, renewal, restoration or reinstatement of a certificate; (l) The imposition of a penalty for a violation of any provision of the regulations; and (m) The confidentiality of any record or other information maintained by the Board relating to an applicant or the holder of a certificate. 3. A person shall not engage in any activity for which the Board requires a certificate as a detoxification technician pursuant to this section unless the person is the holder of such a certificate. 4. In addition to the provisions of subsection 2, a regulation adopted pursuant to this section must include provisions that are substantially similar to the requirements set forth in NRS 641C.280 and 641C.710. Any provision included in a regulation pursuant to this subsection remains effective until the provisions of NRS 641C.280 and 641C.710 expire by limitation. 5. Except as otherwise provided in this section and NRS 641C.900, 641C.910 and 641C.950, the provisions of this chapter do not apply to the holder of a certificate that is issued in accordance with a regulation adopted pursuant to this section. 6. As used in this section, “detoxification technician” means a person who is certified by the Board to provide screening for the safe withdrawal from alcohol and other drugs. (Added to NRS by 2003, 1163; A 2005, 794, 2766)
Cultural competenceThe program has ensured that all clinical staff entrusted with the safety, treatment, monitoring and recording of clients progress have completed SAPTA/BLC approved training, including, but not limited to:-acute withdrawal symptoms from drug and alcohol abuse-first aide procedures for clients with seizures-communicable diseases, including, but not limited to tuberculosis and HIV (“Guidelines for Preventing the Transmission of Tuberculosis in Health-Care Settings, with Special Focus on HIV-Related Issues/Tuberculosis: What the Physician should know.”)-current certification in cardiopulmonary resuscitation (CPR)[NAC 458.168(f-g); NAC 458.108 (1) (b) (2) (b); NAC 458.158 (3) (b-c)] [NRS 458.025; NRS 458.055] [42 C.F.R. 8.12 (b)] Handout Department of HHS Requirements are in NRS 449 and 641 C
Why Report?The primary objectives of disease surveillance are to: Protect the health of the public; Determine the extent of morbidity within the community; Evaluate risk of transmission; and Intervene rapidly when appropriate.
American Medical Society declared a diseaseLegal
Key points in III.2-D: 1) emphasis on peer and social support 2) must be in appropriately licensed or healthcare facility 3) availability of specialized clinical consultation and supervision for biomedical, emotional, behavioral, cognitive problems 4) direct affiliation with other levels of care e) ability to arrange for appropriate laboratory and toxicology tests 5) staffed by appropriately credentialed personnel who are trained and competent to implement physician-approved protocols for patient observation and supervision, determination of appropriate level of care and facilitation to continuing care 6) a clinically managed detoxification service designed explicitly to safely detoxify patients without the need for ready on-site access to medical and nursing personnel h) medical evaluation and consultation is available 24-hours a day, in accordance with treatment/ transfer guidelines 7) all physicians who assess and treat patients are able to obtain and interpret information based on knowledge understood about signs and symptoms of alcohol and other drug intoxication/withdrawal in conjunction with the monitoring and treatment of those conditions and facilities into ongoing care 8) state or federal law supports the policies and procedures in those facilities that supervise self-administered medications by appropriately licensed staff 9) staff assure that patients are taking medications according to physician and legal requirements l0) therapies address and assess patient needs 11 clinical services include appropriate medical services, individual and group therapies/withdrawal support 12) clinically necessary therapies are prescribed on the basis of progress and needs identified in ASAM dimensions 2-6 13) therapies include cognitive, mental health, medical and are administered in group/individual to enhance the patients understanding of detoxification, addiction and referral to the appropriate level of continuing care 14) multidisciplinary individualized assessment and treatment including health education services, families/significant others 15) addiction focused hx in initial assessment and reviewed with physician during admission 16) if physician-developed protocols indicate a concern an appropriately licensed medical professional will engage in medical examination/detoxification medication concerns 17) ASAM dimensions 2-6 involved in biopsychosocial identifying priority needs of the patient and related appropriate level of care 18) individualized treatment plan with problem identification drawn from ASAM placement criteria in dimensions 2-6; discharge/transfer planning beginning at admission; referral arrangements made as needed 19) daily assessment through patient progress and treatment changes; progress notes reflecting treatment plan and patient’s response to treatment 20) detoxification flow/rating sheets used as needed w) patient meets DSM IV TR diagnostic criteria for substance induced disorder and ASAM placement criteria for III.2-D (Continued; social detox; ASAM) 21) patient experiencing signs and symptoms of withdrawal or that withdrawal is imminent 22) patient is assessed as not being at risk for severe withdrawal and is safely manageable at the III.2-D level of service 23) patient is assessed as not requiring medication but requires this service level to complete detoxification and enter a level of ongoing recovery as evidenced by: unsafe home environment for detoxification, insufficient coping skills for recovery environments or previous attempts at detoxification (as evidenced by continued use of other than prescribed medications or other mood and mind altering drugs) at lesser levels of service have been resulted in uncompleted detoxifications, insufficient copings skills and minimal entry into addiction treatment a) patient remains at III.2-D until withdrawal symptoms allow patient to be treated at a lesser level of care b) patient’s signs and symptoms have resulted in an increased intensity as assessed by CIWA-Ar or other standardized scoring indicating a need for transfer to a more intensive level of detoxification See resource
Key points for III.7-D: a) the withdrawal signs and symptoms are sufficiently severe to require 24 hr inpatient care b) twenty four hour observation, monitoring and treatment are available c) the full resources of an acute general care hospital or a medically managed intensive inpatient treatment program are not necessary.
Before we can talk about evaluation lets back up- do a little crash course on ASAM or HDC Guidelines-
Persons undergoing withdrawal are in profound medical and personal crisis!
Look at flow sheet Policies for when client no longer meets criteria
See handout of evaluation
Cocaine and other drugs of abuse can alter dopamine function. Such drugs may have very different actions. The specific action depends on which dopamine receptors the drugs stimulate or block, and how well they mimic dopamine. Drugs can act directly or indirectly on dopamine receptors Drugs such as cocaine and amphetamine produce their effects by changing the flow of neurotransmitters. These drugs are defined as indirect acting because they depend on the activity of neurons. In contrast, some drugs bypass neurotransmitters altogether and act directly on receptors. Such drugs are direct acting. Use of these two types of drugs can lead to very different results in treating the same disease. As mentioned earlier, people with Parkinson's disease lose neurons that contain dopamine. To compensate for this loss, the body produces more dopamine receptors on other neurons. Indirect agonists are not very effective in treating the disease since they depend on the presence of dopamine neurons. In contrast, direct agonists are more effective because they stimulate dopamine receptors even when dopamine neurons are missing.
Chronic methamphetamine abuse also significantly changes the brain. Specifically, brain imaging studies have demonstrated alterations in the activity of the dopamine system that are associated with reduced motor speed and impaired verbal learning. Recent studies in chronic methamphetamine abusers have also revealed severe structural and functional changes in areas of the brain associated with emotion and memory, which may account for many of the emotional and cognitive problems observed in chronic methamphetamine abusers.
Cocaine has other actions in the brain in addition to activating reward. Scientists have the ability to see how cocaine actually affects brain function in people. The PET scan allows one to see how the brain uses glucose; glucose provides energy to each neuron so it can perform work. The scans show where the cocaine interferes with the brain's use of glucose - or its metabolic activity. The left scan is taken from a normal, awake person. The red color shows the highest level of glucose utilization (yellow represents less utilization and blue shows the least). The right scan is taken from a cocaine abuser on cocaine. It shows that the brain cannot use glucose nearly as effectively - show the loss of red compared to the left scan. There are many areas of the brain that have reduced metabolic activity. The continued reduction in the neurons' ability to use glucose (energy) results in disruption of many brain functions.
Management of alcohol withdrawal is based on the patient's history and current clinical status. The single best predictor of the likelihood of future withdrawal symptoms when alcohol is concerned is the patient's previous history, e.g., the presence or absence of seizures or delirium tremens (Table 1).
methamphetamine is structurally similar to amphetamine and the neurotransmitter dopamine, but it is quite different from cocaine. Although these stimulants have similar behavioral and physiological effects, there are some major differences in the basic mechanisms of how they work. In contrast to cocaine, which is quickly removed and almost completely metabolized in the body, methamphetamine has a much longer duration of action and a larger percentage of the drug remains unchanged in the body. This results in methamphetamine being present in the brain longer, which ultimately leads to prolonged stimulant effects. And although both methamphetamine and cocaine increase levels of the brain chemical dopamine, animal studies reveal much higher levels of dopamine following administration of methamphetamine due to the different mechanisms of action within nerve cells in response to these drugs. Cocaine prolongs dopamine actions in the brain by blocking dopamine re-uptake. While at low doses, methamphetamine blocks dopamine re-uptake, methamphetamine also increases the release of dopamine, leading to much higher concentrations in the synapse, which can be toxic to nerve terminals.
is an inability to experience pleasurable emotions from normally pleasurable life events such as eating, exercise, social interaction or sexual activitiesAnhedonia is often experienced by drug addicts following withdrawal; in particular, stimulants like cocaine and amphetamines cause anhedonia and depression by depleting dopamine and other important neurotransmitters. Very long-term addicts are sometimes said to suffer a permanent physical breakdown of their pleasure pathways, leading to anhedonia on a permanent or semi-permanent basis due to the extended overworking of the neural pleasure pathways during active addiction, particularly as regards to cocaine and methamphetamine. In this circumstance, activities still may be pleasurable, but can never be as pleasurable to people who have experienced the comparatively extreme pleasure of the drug experience. The result is apathy towards healthy routines by the addict.
Alcohol withdrawal is characterised by neuropsychiatric excitabilityThe severity of the alcohol withdrawal syndrome can vary from mild symptoms such as mild sleep disturbances and mild anxiety to very severe and life threatening including delirium, particularly visual hallucinations in severe cases and convulsions (which may result in death).[5] The severity of alcohol withdrawal depends on various factors including age, genetics and most importantly degree of alcohol intake and length of time the individual has been misusing alcohol for and number of previous detoxifications.[6][7]
Medications such as benzodiazepines are effective in the treatment of withdrawal syndromes, and naltrexone and disulfiram can be used to augment relapse prevention. Patients may also participate in psychosocial methods of addiction treatment that can reduce the risk of relapse and improve their psychosocial, health, legal and employment status.
Agents that are commonly recommended include diazepam (Valium), lorazepam (Ativan), chlordiazepoxide (Limbitrol), clorazepate (Tranxeme) and phenobarbital. The usual initial dosage of diazepam or lorazepam is titrated according to elevations of blood pressure, pulse rate, degree of agitation and presence of delirium. In general, longer-acting preparations such as diazepam or chlordiazepoxide provide a smoother and safer withdrawal than other preparations. Shorter-acting preparations such as lorazepam are indicated when elimination time for benzodiazepines is prolonged, such as in patients with significant liver disease.Valium- may also be called Diazepam, and is one of the Benzodiazepine group of medicines. These are Central Nervous System (CNS) depressants and are used to relieve anxiety. Valium is also used to help relax muscles or relieve muscle spasm. In general, longer-acting preparations such as diazepam or chlordiazepoxide provide a smoother and safer withdrawal than other preparations. Clonidine lowers blood pressure by decreasing the levels of certain chemicals in your blood. This allows your blood vessels (veins and arteries) to relax (widen) and your heart to beat more slowly and easily. is a direct-acting α2 adrenergic agonist prescribed historically as an antihypertensive Atenolol or Tenormin- is one of a group of medicines is known as beta-adrenergic blocking agents, beta-blocking agents, or beta-blockers. Atenolol is used in the treatment of high blood pressure, used to relieve angina, and in heart attack patients to help prevent additional heart attacks. Atenolol is also used to correct irregular heartbeat, prevent migraine headaches, and to treat tremors. Lorazepam Ativan-Lorazepam (also known by its brand name Ativan or Temesta) is a benzodiazepine drug with short to medium duration of action. It has all five intrinsic benzodiazepine effects: anxiolytic, sedative/hypnotic, anticonvulsant and muscle relaxant, to different extents.[4] It is a powerful anxiolytic and since its introduction in 1971, lorazepam's principal use has been in treating the symptom of anxiety. It is a unique benzodiazepine insofar as it has also found use as an adjunct antiemetic in chemotherapy. Among benzodiazepines, lorazepam has a relatively high addictive potential.[5]Shorter-acting preparations such as lorazepam are indicated when elimination time for benzodiazepines is prolonged, such as in patients with significant liver disease.
p. 65
Only 5% of patients with ethanol withdrawal progress to DT. The mortality rate may be as high as 35% if untreated but is less than 5% with early recognition and treatment. Patients at greatest risk for death are those with extreme fever, fluid and electrolyte imbalance, or intercurrent illness such as pneumonia, hepatitis, or pancreatitis.
clonidine (Catapres) or methadone.Opiates are powerful drugs derived from the poppy plant that have been used for centuries to relieve pain. They include opium, heroin, morphine, and codeine. Even centuries after their discovery, opiates are still the most effective pain relievers available to physicians for treating pain. Although heroin has no medicinal use, other opiates, such as morphine and codeine, are used in the treatment of pain related to illnesses (for example, cancer) and medical and dental procedures. When used as directed by a physician, opiates are safe and generally do not produce addiction. But opiates also possess very strong reinforcing properties and can quickly trigger addiction when used improperly.
Mydriasis is an excessive dilation of the pupil due to disease, trauma or drugs. Normally, the pupil dilates in the dark and constricts in the light. A mydriatic pupil will remain excessively large, even in a bright…Medications such as benzodiazepines are effective in the treatment of withdrawal syndromes, and naltrexone and disulfiram can be used to augment relapse prevention. Patients may also participate in psychosocial methods of addiction treatment that can reduce the risk of relapse and improve their psychosocial, health, legal and employment status.
Add notes from p 97-98Biggest concern is intoxication/severe intoxication with overdoseNeuorotoxicityPersistent psychiatric and neurologic symptoms
Add notes from p 97-98Biggest concern is intoxication/severe intoxication with overdoseNeuorotoxicityPersistent psychiatric and neurologic symptoms
P 77 TIPS manual
Profile record should be the first or bottom record in the client activity list – this is controlled by profile dateAlways assume there is a profile for the client before creating one – in other words, search for a profile before entering a new one If your agency has multiple treatment locations where intake could occur, techs and counselors should have access to view client records from the Business Level and should also have the ability to move to any treatment location within the system to share records with the detox treatment location TURN YOUR POPUP BLOCKER OFF BEFORE ENTERING A NEW CLIENT PROFILE – this way, if one already exists at your agency, the system will find it and notify youEnter only the city in Birth City field
Blood Pressure: This is the force of the blood pushing against the walls of the arteries in the body. There are two numbers associated with blood pressure. The higher number is called the systolic pressure which represents the pressure while the heart contracts to pump blood to the body. The lower number which is called the diastolic pressure represents the pressure when the heart relaxes between beats. A normal systolic adult resting blood pressure is from 110-140 and a normal diastolic pressure is from 60-80.Step 10 SphygmomanometerThere are two kinds of blood pressure methods. The first one is using a stethoscope and a device called a sphygmomanometer (try spelling that one for a test!). Have the patient expose their arm. This is better to get a more accurate reading. Place the bottom edge of the cuff about one inch above the brachial artery (found in the inner area of your bent elbow). The cuff should be at the level of the heart. Wrap around the patient's arm. Make sure it is wrapped around snug, not too tight but not falling off the patient's arm. Close the valve on the bulb. Place your stethoscope on the patient's brachial artery and start pumping the bulb up to about 180. Slowly release the valve. Note when you first hear the pulse. This is the systolic pressure. Once the pulse goes away, this is the diastolic pressure.Step 11The second way to measure a patient's blood pressure is by using an automatic blood pressure device. Follow the same directions in the step above yet you will not need to figure out the noises nor use a stethoscope